Cellectar Biosciences, Inc. Increase (Decrease) in Other Operating Assets
Cellectar Biosciences, Inc. (CLRB) reported Increase (Decrease) in Other Operating Assets of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2021-03-02
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2020-03-31 was $0.00.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2019-06-30 was -$465.82K, a 459.04% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2019-03-31 was -$11.87K, a 123.75% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2018-12-31 was -$138.94K.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2019 was -$477.69K, a 688.19% decline from fiscal 2018.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2018 was $81.21K, a 82.85% decline from fiscal 2017.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2017 was $473.46K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | -$477.69K 10-K · filed 2021-03-02 | |||
| 2019-06-30 | -$465.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$477.69K 10-Q · filed 2020-08-10 | -$616.64K derived: sum of 3 quarters · filed 2020-08-10 | -$576.20K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$11.87K 10-Q · filed 2020-05-07 | -$150.82K derived: sum of 2 quarters · filed 2020-05-07 | -$110.38K derived: sum of 3 quarters · filed 2020-05-07 | $19.36K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$138.94K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$98.51K derived: sum of 2 quarters · filed 2020-03-09 | $31.23K derived: sum of 3 quarters · filed 2020-03-09 | $81.21K 10-K · filed 2020-03-09 |
| 2018-09-30 | $40.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $170.18K derived: sum of 2 quarters · filed 2019-11-12 | $220.16K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $129.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $179.72K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $49.98K 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $473.46K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |